e-learning
resources
Virtual 2020
Pre-Congress Content
Phenotypes of obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characterisation of the neutrophilic asthma phenotype over time.
C. Blouin (Quebec, Canada), K. Godbout (Quebec, Canada), M. Boulay (Quebec, Canada), A. Bhalla (Hamilton, Canada), P. Nair (Hamilton, Canada), L. Boulet (Quebec, Canada), A. Côté (Quebec, Canada)
Source:
Virtual Congress 2020 – Phenotypes of obstructive diseases
Session:
Phenotypes of obstructive diseases
Session type:
E-poster session
Number:
1242
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Blouin (Quebec, Canada), K. Godbout (Quebec, Canada), M. Boulay (Quebec, Canada), A. Bhalla (Hamilton, Canada), P. Nair (Hamilton, Canada), L. Boulet (Quebec, Canada), A. Côté (Quebec, Canada). Characterisation of the neutrophilic asthma phenotype over time.. 1242
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Characteristics, definition and phenotypes of severe asthma
Source: Eur Respir Mon 2011; 51: 50-58
Year: 2011
Evidence of a distinct phenotype of adult onset asthma characterized by an airway neutrophilia and poor response to inhaled corticosteroids
Source: Eur Respir J 2001; 18: Suppl. 33, 21s
Year: 2001
The role of neutrophilic inflammation in asthma of different severity
Source: Eur Respir J 2002; 20: Suppl. 38, 310s
Year: 2002
Increased sputum B cells in severe eosinophilic asthma: a local auto-inflammatory process
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018
A 4-week model of allergic airways inflammation that exhibits the 3 salient features of asthma.
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
Evolution of asthma in relation to the bronchial inflammatory phenotype: a follow-up study
Source: International Congress 2018 – Asthma analysis
Year: 2018
Conclusion: clinical phenotypes of asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005
Opioid-neurotensin hybrid influences pulmonary inflammatory process in murine model of non-atopic asthma.
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017
Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
Neutrophilic asthma features increased airway classical monocytes
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
Identifying eosinophil subsets in a mouse model of pollutant-aggravated allergic asthma
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021
Chronic persistence of human ?-herpesviruses and regulatory cells phenotypes in severe bronchial asthma.
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017
Neutrophilic asthma: a distinct phenotype?
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
Increased numbers of alveolar mast cells with an altered phenotype are linked to peripheral airway remodelling in patients with allergic asthma
Source: Annual Congress 2012 - Mechanisms of asthma
Year: 2012
Clinical and inflammatory determinants of (the course of) bronchial hyperresponsiveness in COPD
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010
Features of FeNO-high asthma phenotype
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Stability of the eosinophilic phenotype in stable and exacerbated COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Disruption of CD44 variant 6 abolished bronchial hyperresponsiveness, inflammation and mast cell myositis in a murine model of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 217s
Year: 2006
Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept